METABOGEN
Metabogen is an operator of a research and development company intended to offer biomarker and personalized treatment services. The company's services include integrating metagenomic data analysis with subsequent development and clinical programs as well as specializes in the identification and improvisation of indication-related bacterial strains, enabling probiotic industry to develop novel diagnostic tests and treatments.
METABOGEN
Industry:
Pharmaceutical
Founded:
2011-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.metabogen.se
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
16.6 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.metabogen.se
- Host name: 172.67.218.191
- IP address: 172.67.218.191
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Metabogen"
MetaboGen Expands Its Organization – Metabogen
MetaboGen expands its organization by recruiting Sara Malcus as CEO, Bo Möllstam for Business Development and Fredrik Karlsson as Product Development Manager.See details»
Metabogen - Crunchbase Company Profile & Funding
Metabogen is an operator of a research and development company intended to offer biomarker and personalized treatment services. The company's services include integrating …See details»
MetaboGen Company Profile 2024: Valuation, Investors
Operator of a metagenome research and development company intended to develop novel therapeutics and next-generation probiotics.See details»
MetaboGen AB - LinkedIn
As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and next generation probiotics.See details»
MetaboGen AB - Craft
Since 2011, the company provides commercial access to metagenome research and development, helping the industry to create next generation probiotics and pharmaceutical …See details»
Metabogen - Products, Competitors, Financials, Employees, …
Metabogen, founded in 2011, provides commercial access to metagenome research and development, helping the industry to create next generation probiotics and pharmaceutical …See details»
MetaboGen - VentureRadar
MetaboGen works to develop products from novel bacterial strains, targeted for precise indications and derived from the human gut microbiome. Products may be food supplements, …See details»
Metabogen – Funding, Valuation, Investors, News | Parsers VC
Aug 29, 2022 · Metabogen provides commercial access to metagenome research and development, helping the industry to create next ta probiotics and pharmaceutical products, …See details»
Metabogen AB Company Profile | Stockholm, Stockholm, Sweden ...
Find company research, competitor information, contact details & financial data for Metabogen AB of Stockholm, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
Metabogen - GU Ventures
Metabogen provides commercial access to metagenome research and development, helping the industry to create next ta probiotics and pharmaceutical products, based on the microbiome.See details»
BioGaia becomes full owner of MetaboGen – BioGaia
Jul 2, 2021 · With our full ownership of MetaboGen we’ll be able to accelerate the development of new probiotic strains, in particular the strict anaerobic bacteria which are part of our pipeline.See details»
MetaboGen AB - Company Profile and News - Bloomberg Markets
Metabogen AB operates as a research company. The Company provides commercial access to metagenome research and development, helping the industry to create next generation …See details»
2021 November – Metabogen
Nov 2, 2021 · New members of the MetaboGen family! We are all so happy to be back in full force after a challenging pandemic period, and extra happy to announce that the MetaboGen team …See details»
New members of the MetaboGen family! – Metabogen
Nov 1, 2021 · New members of the MetaboGen family! We are all so happy to be back in full force after a challenging pandemic period, and extra happy to announce that the MetaboGen team …See details»
Metabogen - Company info. interviews, news - BiopharmaTrend
Mar 18, 2020 · As a pioneering company addressing the microbiome to understand health and disease, MetaboGen is creating breakthrough opportunities to develop novel therapeutics and …See details»
MetaboGen has reached a new crucial milestone in its …
Feb 12, 2021 · After obtaining positive results in the initial clinical study with the strains Faecalibacterium prausnitzii (DSM 32379) and Desulfovibrio piger (DSM 32187), MetaboGen …See details»
MetaboGen - research.chalmers.se
MetaboGen is a biomarker and personalized treatment company using proprietary metagenomic phenotyping of the gut microbiota to identify new biomarkers, develop novel diagnostic tests …See details»
BioGaia invests further in MetaboGen – Metabogen
On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a 62 percent stake. BioGaia has now, after the set milestones have been achieved, decided to further …See details»
MFN.se > BioGaia > BioGaia: MetaboGen has reached a new …
Feb 12, 2021 · MetaboGen aims at developing next generation probiotic products focusing on metabolic conditions with special emphasis on diabetes and related diseases. The company …See details»
BioGaia increases further in MetaboGen
Apr 6, 2018 · BioGaia thereafter owned 36 percent of the share capital of MetaboGen. Research on the microbiome is developing very rapidly and pharmaceutical companies make major …See details»